These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30847368)

  • 41. Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke: A propensity score-matched cohort with 5-year follow-up.
    Heo NH; Lee MR; Yang KH; Hong OR; Shin JH; Lee BY; Lee JY; Ahn JM; Oh HJ; Oh JS
    Medicine (Baltimore); 2021 Nov; 100(44):e27652. PubMed ID: 34871239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is intravenous thrombolysis still necessary in patients who undergo mechanical thrombectomy?
    Katsanos AH; Tsivgoulis G
    Curr Opin Neurol; 2019 Feb; 32(1):3-12. PubMed ID: 30461464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.
    Amaro S; Soy D; Obach V; Cervera A; Planas AM; Chamorro A
    Stroke; 2007 Jul; 38(7):2173-5. PubMed ID: 17525395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
    Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
    J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous thrombolysis in the treatment of ischemic stroke due to spontaneous artery dissection.
    Budimkić MS; Berisavac I; Beslać-Bumbaširević L; Savić O; Stanarčević P; Ercegovac MD; Pađen V; Jovanović DR
    Neurologist; 2012 Sep; 18(5):273-6. PubMed ID: 22931732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
    Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation.
    Suwanwela NC; Phanthumchinda K; Likitjaroen Y
    Clin Neurol Neurosurg; 2006 Sep; 108(6):549-52. PubMed ID: 16289309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pennsylvania comprehensive stroke center collaborative: Statement on the recently updated IV rt-PA prescriber information for acute ischemic stroke.
    Daou B; Deprince M; D'Ambrosio R; Tjoumakaris S; Rosenwasser RH; Ackerman DJ; Bell R; Tzeng DL; Ghobrial M; Fernandez A; Shah Q; Gzesh DJ; Murphy D; Castaldo JE; Mathiesen C; Pineda MC; Jabbour P
    Clin Neurol Neurosurg; 2015 Dec; 139():264-8. PubMed ID: 26539671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.
    Liang Z; Zhang J; Huang S; Yang S; Xu L; Xiang W; Zhang M
    BMC Neurol; 2022 Jul; 22(1):280. PubMed ID: 35897006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT.
    Zonneveld TP; Algra A; Dippel DW; Kappelle LJ; van Oostenbrugge RJ; Roos YB; Wermer MJ; van der Worp HB; Nederkoorn PJ; Kruyt ND;
    BMC Neurol; 2015 Nov; 15():241. PubMed ID: 26596237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years.
    Mione G; Ducrocq X; Thilly N; Lacour JC; Vespignani H; Richard S
    Geriatr Gerontol Int; 2016 Jul; 16(7):843-9. PubMed ID: 26245693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.